NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

SBTDC IRE logo
North Carolina’s Small Business and Technology Development Center is hosting a two-day workshop for entrepreneurs starting Wednesday, Dec. 2
Amnion foundation logo
Academic scientists at NC universities receive the first seed grants from the Amnion Foundation for research projects that will study cells derived from birth tissue to better understand fetal health and cancer.
James Siedow, Ph.D.
Former Duke University science educator and researcher and NCBiotech board member James (Jim) Siedow, Ph.D., has died. 
Verona Pharma logo
Verona Pharma has landed an additional $30 million in financing to support its “first-in-class” drug candidate, ensifentrine, targeting chronic obstructive pulmonary disease (COPD).
Gene snip Shutterstock
Eli Lilly and Durham gene editing innovator Precision Biosciences announced a research collaboration and exclusive license agreement that could potentially be worth over a half billion dollars
Kimberly Smith, MD, MPH
Kimberly Smith, M.D., MPH, SVP and head of research and development of ViiV Healthcare in RTP, is hailed as one of the top 20 among 2020’s "Fiercest Women in Life Sciences."
IPM Chirana's ventilator
IPM Chirana, a global company that makes ventilators to treat critical care patients, has selected Research Triangle Park as the site of its U.S. headquarters.
Locus logo
Morrisville-based Locus Biosciences has signed an agreement with a global non-profit to help fund a new CRISPR Cas3 antibacterial therapy to treat recurrent urinary tract infections.
Verona Pharma entry
Verona Pharma, a British clinical-stage biotech firm with U.S. headquarters in Raleigh, is exploring the option of repurposing its leading drug candidate to treat COVID-19 patients.
NCBiotech awarded 11 grants and loans totaling $623,136 to bioscience companies, universities and nonprofit organizations in the first quarter of its fiscal year.
Avient Biosciences facility
Avient Biosciences' new hemp and research and extraction facility is prepared to produce pharmaceutical ingredients.
Merck Hillman Center
Merck enters an agreement to buy clinical-stage startup VelosBio for $2.75 billion.
Advanced Chemotherapy Technologies
Raleigh's Advanced Chemotherapy Technologies announces $5.5M in Series A to fund tests of its medical device offering targeted delivery of chemotherapy to the pancreas in humans.

BioCryst logoThe United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted Durham-based BioCryst Pharmaceuticals’ berotralstat a positive scientific opinion through the Early Access to Medicines Scheme.

410 Medical LifeFlow device
Durham startup 410 Medical has received FDA 510(k) Clearance for its LifeFlow PLUS Blood and Fluid Infuser (LifeFlow PLUS).